Xeris Pharmaceuticals | Fortjeneste Per Aksje



Eps Endring Dato
Adcock Ingram Holdings ZAR 2.59 0.17 2024-12
Celltrion KRW 395.45 36.4 2024-09
Cspc Pharmaceutical CNY 0.06 0.05 2024-09
Dianthus Therapeutics USD -0.74 0.23 2024-09
Ecofibre AUD -0.05 0.05 2024-12
Eli Lilly USD 5.32 4.14 2024-12
Kangmei Pharma CNY 0 0 2024-09
Knight Therapeutics CAD 0 0.02 2024-09
Laboratorios Farma 0.55 1.41 2024-06
Malin Corporation 0 0 2024-12
Medical Developments International AUD 0 0.34 2024-12
Neuren Pharmaceuticals AUD 1.02 0.96 2024-12
Organigram Holdings CAD -0.2 0.12 2024-12
Pacira USD 0.91 0.12 2024-12
Perrigo USD 0.93 0.12 2024-12
Pharma Mar EUR 1.08 0.87 2024-12
Qiagen NV USD 0.59 0.06 2024-12
Sartorius EUR 1.04 0.83 2024-12
Sino Biopharmaceutical CNY 0.08 0.04 2024-06
Supernus Pharmaceuticals USD 0.75 0.42 2024-12
Tilray USD -0.1 0.05 2024-11
Zhangzhou Pientzehuang Pharmaceutical 1.6 0.37 2024-09



Xeris Pharmaceuticals Fortjeneste Per Aksje - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Mar 2025.